24/02/2025
The *Zimbabwe Haemophilia Association (ZHA)* is delighted to announce that the journey towards designing the Zimbabwe Haemophilia Treatment Guidelines, supported by the Novo Nordisk Haemophilia Foundation (NNHF), is almost complete.
On Saturday 19 February 2025, ZHA, alongside doctors and other healthcare professionals from the *Haematology Research Trust of Zimbabwe*, convened at the Bronte Hotel in Harare to review and provide input on the first draft of the treatment guidelines. These guidelines have been designed to provide practical and accessible guidance for primary healthcare practitioners who might not be familiar with haemophilia management, as well as to summarise best practices for practitioners at secondary and tertiary healthcare levels.
These guidelines will be instrumental in bringing the requisite knowledge to healthcare facilities around the country. ZHA has observed that most facilities have faced challenges in knowing how to manage haemophilia patients or even administer infusions when factor concentrates were available. These guidelines will now offer much-needed confidence to healthcare professionals, not just in the capital at Parirenyatwa National Hospital, where NNHF has supported the establishment of a third-level comprehensive care facility, but across the country where we intend to disseminate the guidelines once endorsed by the Ministry of Health.
As a patient association, we hope the guidelines will provide relief to patients who have had to endure long hours of travel to reach the capital for manageable cases at their nearest facilities. The Zimbabwe Haemophilia Association is thankful to the Ministry of Health, the Haematology Research Trust of Zimbabwe, doctors, and other healthcare professionals who dedicated their time and expertise to this process, as well as to its members and the *Novo Nordisk Haemophilia Foundation (NNHF)*.